The major brands in China’s urinalysis market are URIT, DIRUI, AVE, etc. URIT produced China’s first urine analyzer in 1984. And after nearly 40 years’ strenuous cultivation, it pioneered the modular urine analysis workflow using deep learning artificial intelligence (AI) image recognition technology.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Molecular testing company Predicine said on Tuesday that its blood and urine cell-free DNA (cfDNA) assay, PredicineCare, has secured a CE-IVD mark.

Recently, the localization project of QIAGEN has received another good news. The automatic nucleic acid extraction instrument QIAcube HT has been received the first-class medical device filing approval

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announced today that it has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics

Pfizer Inc. (NYSE: PFE) and Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the companies have entered into a definitive agreement under which Pfizer will acquire GBT, a biopharmaceutical company dedicated to the discovery, development and delivery of life

Recently, ByteDance completed the wholly-owned acquisition of Meizhong Yihe, a high-end private women's and children's hospital.

China has reported 35 cases of a novel Langya henipavirus that likely spread from animals to humans and can cause renal and liver failure

Hyris said on Friday that it has received CE-IVD marking for its T-Cell Test for tracking and monitoring T-cell immunity to SARS-CoV-2.

On August 5, the strategic signing ceremony between Wuhan Ammunition Life Technology Co., Ltd. and the internationally renowned company Roche Diagnostics was successfully held in Wuhan.

QuidelOrtho reported after the close of the market Thursday that its second quarter revenues rose 38 percent year over year, which the firm attributed in part to growth in its point-of-care and molecular diagnostics businesses.

Meridian Bioscience reported on Friday morning a 7 percent year-over-year increase in its fiscal third quarter revenues, one month after announcing it will be acquired by a newly formed affiliate of SD Biosensor and SJL Partners.